[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.202.12. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 543
Citations 0
Correction
November 14, 2012

Error in Text in: Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial

JAMA. 2012;308(18):1861. doi:10.1001/jama.2012.14674

Error in Text. In the Original Contribution entitled “Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial” published in the July 11, 2012, of JAMA (2012;308[2]:147-156), the median survival for the ampullary pancreatobiliary group was transposed with the median survival for the ampullary intestinal group. This article has been corrected online.

×